Dissecting the role of ApiAP2 proteins in transcriptional regulation during Plasmodium falciparum development

剖析 ApiAP2 蛋白在恶性疟原虫发育过程中转录调控中的作用

基本信息

  • 批准号:
    9271152
  • 负责人:
  • 金额:
    $ 38.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-11 至 2021-04-30
  • 项目状态:
    已结题

项目摘要

Although for many years it was thought that Plasmodium parasites, the causative agents of malaria, were devoid of sequence-specific transcription factors, work from our lab and others has now demonstrated that they possess a limited number of such regulatory proteins. The apicomplexan AP2 (ApiAP2) proteins, which are plant-like in their origin, are now widely considered to be the single major family of DNA binding proteins identified in the Plasmodium genome. Our central hypothesis is that members of the ApiAP2 protein family are the major regulators of development throughout the complete lifecycle of the malaria parasite. ApiAP2 proteins are highly variable in size and contain anywhere from one to three AP2 DNA binding domains. We have measured the DNA binding specificities for all AP2 domains from Plasmodium demonstrating a broad array of DNA sequence specificities. By determining the genome-wide occurrence of these DNA motifs, we can begin to predict the functional roles for some ApiAP2 proteins. However, detailed mechanistic studies to confirm these predictions have been lagging. This proposal seeks to define the functional role for a subset of ApiAP2 proteins associated with processes critical to blood-stage development including the regulation of red blood cell invasion, commitment to gametocytogenesis and gametocyte differentiation and maturation. First, we will define the transcriptional regulatory network of PfAP2-G (PF3D7_1222600), which we have demonstrated to be a master regulator of sexual stage commitment. We will also investigate two additional ApiAP2 proteins implicated in gametocyte development (PF3D7_1317200, PF3D7_1408200) to define their role in the regulation of gametocyte differentiation. We next propose to characterize the role of PF3D7_1007700, which we predict to be a regulator of red blood cell invasion. Since PF3D7_1007700 contains three AP2 DNA binding domains, each with unique DNA binding specificity, this will allow us to dissect the contribution of individual AP2 domains to the function of this protein (and other ApiAP2 proteins by analogy). Lastly, we have identified a new conserved domain in ApiAP2 proteins and will initiate efforts to characterize the structure and function of this domain as well as seeking to define transactivation regions within these proteins. To accomplish our goals, we will use a combination of established techniques, including genetic manipulation of the parasite, biochemistry, and genome-wide approaches. Understanding the molecular mechanisms of transcriptional regulatory processes in P. falciparum will provide critically needed tools for studying parasite development, and also presents therapeutic targets for new intervention strategies aimed at blocking parasite maturation. ApiAP2 proteins are strictly found in Apicomplexan parasites and therefore are attractive candidates for new antimalarial therapies.
尽管多年来人们一直认为疟原虫是疟疾的病原体, 缺乏序列特异性转录因子,我们实验室和其他人的工作现在已经 表明它们拥有有限数量的这种调节蛋白。apicomplexan AP 2 ApiAP 2蛋白,其起源类似于植物,现在被广泛认为是唯一的主要的蛋白质。 在疟原虫基因组中鉴定的DNA结合蛋白家族。我们的核心假设是, ApiAP 2蛋白家族的成员是整个发育过程中的主要调节因子。 疟疾寄生虫的整个生命周期。ApiAP 2蛋白在大小上高度可变,并且含有 从一个到三个AP 2 DNA结合结构域。我们测量了DNA结合 对疟原虫所有AP 2结构域的特异性,证明了广泛的DNA序列 特殊性通过确定这些DNA基序在全基因组范围内的出现,我们可以开始 预测一些ApiAP 2蛋白的功能作用。然而,详细的机制研究, 证实了这些预测是滞后的。这项建议旨在界定一个机构的职能作用, ApiAP 2蛋白的一个子集,与血液阶段发育的关键过程相关,包括 红细胞侵入、配子体发生和配子体定型的调节 分化和成熟。首先,我们将定义PfAP 2-G的转录调控网络 (PF3D7_1222600),我们已经证明它是性阶段的主要调节剂 承诺.我们还将研究另外两种与配子体相关的ApiAP 2蛋白, 发育(PF3D7_1317200,PF3D7_1408200),以确定其在配子体调节中的作用 分化接下来,我们提出表征PF3D7_1007700的作用,我们预测它是一种 红细胞侵入的调节剂。由于PF3D7_1007700包含三个AP 2 DNA结合结构域, 每一个都有独特的DNA结合特异性,这将使我们能够剖析单个AP 2的贡献, 这些结构域与该蛋白质的功能(以及通过类推的其他ApiAP 2蛋白质)相关。最后,我们有 在ApiAP 2蛋白中发现了一个新的保守结构域,并将开始努力表征 该结构域的结构和功能,以及试图在这些结构域中定义反式激活区域, proteins.为了实现我们的目标,我们将结合使用已建立的技术,包括 寄生虫的遗传操纵、生物化学和全基因组方法。了解 恶性疟原虫转录调控过程的分子机制将提供关键的 研究寄生虫发展所需的工具,也提出了新的治疗目标, 旨在阻断寄生虫成熟的干预策略。ApiAP 2蛋白严格存在于 因此,顶复门寄生虫是新的抗疟疗法的有吸引力的候选者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Manuel Llinas其他文献

Manuel Llinas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Manuel Llinas', 18)}}的其他基金

Cofactor metabolism and mitochondrial function in malaria parasites
疟原虫的辅因子代谢和线粒体功能
  • 批准号:
    10659968
  • 财政年份:
    2023
  • 资助金额:
    $ 38.29万
  • 项目类别:
Discovering resistance-resistant antimalarial drug target
发现耐药性抗疟药物靶点
  • 批准号:
    10741535
  • 财政年份:
    2023
  • 资助金额:
    $ 38.29万
  • 项目类别:
Structure of Malaria Parasite RNA polymerase
疟疾寄生虫 RNA 聚合酶的结构
  • 批准号:
    10433276
  • 财政年份:
    2022
  • 资助金额:
    $ 38.29万
  • 项目类别:
Structure of Malaria Parasite RNA polymerase
疟疾寄生虫 RNA 聚合酶的结构
  • 批准号:
    10552645
  • 财政年份:
    2022
  • 资助金额:
    $ 38.29万
  • 项目类别:
Dissecting RNA Regulation During Malaria Parasite Sexual Development
解析疟原虫性发育过程中的 RNA 调控
  • 批准号:
    9375224
  • 财政年份:
    2017
  • 资助金额:
    $ 38.29万
  • 项目类别:
Dissecting the role of ApiAP2 proteins in transcriptional regulation during Plasmodium falciparum development
剖析 ApiAP2 蛋白在恶性疟原虫发育过程中转录调控中的作用
  • 批准号:
    9913444
  • 财政年份:
    2016
  • 资助金额:
    $ 38.29万
  • 项目类别:
Dissecting the role of ApiAP2 proteins in transcriptional regulation during Plasmodium falciparum development
剖析 ApiAP2 蛋白在恶性疟原虫发育过程中转录调控中的作用
  • 批准号:
    9158624
  • 财政年份:
    2016
  • 资助金额:
    $ 38.29万
  • 项目类别:
Regulation of Plasmodium falciparum transcription
恶性疟原虫转录的调控
  • 批准号:
    7767711
  • 财政年份:
    2009
  • 资助金额:
    $ 38.29万
  • 项目类别:
Regulation of Plasmodium falciparum transcription
恶性疟原虫转录的调控
  • 批准号:
    8417773
  • 财政年份:
    2009
  • 资助金额:
    $ 38.29万
  • 项目类别:
Regulation of Plasmodium falciparum transcription
恶性疟原虫转录的调控
  • 批准号:
    8223300
  • 财政年份:
    2009
  • 资助金额:
    $ 38.29万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 38.29万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 38.29万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 38.29万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 38.29万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 38.29万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 38.29万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 38.29万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 38.29万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 38.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 38.29万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了